Clinical Trials Browser

Phase 2 × Vulvar Neoplasms × lenvatinib × Clear all

NCT07290894 2025-12-18

MITO VULVA-01

Phase 2 Not yet recruiting

Vulvar Neoplasms

NCT05903833 2025-09-09

PIERCE

Phase 2 Recruiting

Vulvar Neoplasms